IM027068
Recruiting
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
Researchers hope to learn more about BMS 986278. The study treatment will be tested at doses of either 120 mg or 60 mg, compared to placebo. There will be 2 cohorts and up to 1185 subjects participating.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 854918
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
